Facultad de Medicina
Facultad
Hospital de Terrassa
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Terrassa (12)
2024
-
Timing of previous heart failure hospitalization as a prognostic factor for emergency department heart failure patients
Internal and Emergency Medicine, Vol. 19, Núm. 4, pp. 1089-1098
2023
-
QT interval and short-term outcome in acute heart failure
Clinical Research in Cardiology, Vol. 112, Núm. 12, pp. 1754-1765
2022
-
Ambient temperature and atmospheric pressure at discharge as precipitating factors in immediate adverse events in patients treated for decompensated heart failure
Internal and Emergency Medicine, Vol. 17, Núm. 7, pp. 2045-2056
2021
-
Correction to: Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of the NOVICA-2 study (Clinical Research in Cardiology, (2021), 110, 7, (993-1005), 10.1007/s00392-020-01710-0)
Clinical Research in Cardiology
-
Factors associated with in-hospital mortality and adverse outcomes during the vulnerable post-discharge phase after the first episode of acute heart failure: results of the NOVICA-2 study
Clinical Research in Cardiology, Vol. 110, Núm. 7, pp. 993-1005
-
Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation
European Journal of Internal Medicine, Vol. 94, pp. 73-84
-
Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome
European heart journal, Vol. 42, Núm. 33, pp. 3127-3142
2020
2018
-
Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study
Critical Care, Vol. 22, Núm. 1
-
Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO
Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227
2012
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092